Assessment of coronary artery intimal thickening in patients with a previous diagnosis of Kawasaki disease by using high resolution transthoracic echocardiography: our experience

BMC Cardiovascular Disorders

Salvatore Leonardi¹  Mario La Rosa¹  Patrizia Barone¹  Martina Filippelli¹  Ileana Stella¹  Pietro Sciacca¹  Valentina Giacchi¹ 

[1] Pediatric Pneumo-Allergology and Cystic Fibrosis Department, Pediatric Cardiology Clinic, AOU “Policlinico-Vittorio Emanuele”, University of Catania, Catania, Italy

关键词: Coronary intimal thickening;    Cardiovascular risk;    High resolution transthoracic echocardiography;    Kawasaki disease;   

Others  :  1088466
DOI  :  10.1186/1471-2261-14-106

 received in 2014-05-05, accepted in 2014-08-15,  发布年份 2014

【 摘 要 】

Background

Kawasaki disease (KD) is a generalized systemic vasculitis of unknown etiology involving medium and small size blood vessels, particularly the coronary arteries. In these vessels a progressive stenosis may result from active remodeling with an intimal proliferation and neoangiogenesis. The aim of our study was to assess, by using high-resolution transthoracic 2D Echocardiography, if subjects with a previous diagnosis of Kawasaki disease after several years show a coronary intimal thickening, suggestive of a persistent cardiovascular risk.

Methods

We assessed measurement of thickening, inner diameter and outer diameter of coronary arteries using 2D Echocardiography (Philips E 33 with multy-frequency S8-3 and S12-4 probes) and examining the proximal portion of left main coronary artery just above the aortic valve with parasternal short axis view.

Results

We found a significant intimal thickening in patients with previous Kawasaki disease compared to healthy controls. In particular, we noticed that also subjects not suffering from coronary impairment in acute phase have higher values of thickening than healthy controls, and this wall thickening may confer a higher cardiovascular risk.

Conclusions

Therefore we concluded that the assessment of coronary artery thickening by high-resolution transthoracic 2D Echocardiography may become an essential instrument to evaluate late cardiovascular risk in subjects with a diagnosis of Kawasaki disease in childhood.

【 授权许可】

   
2014 Giacchi et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Kawasaki T: Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 1967, 16:178-222.
• [2]Takeuchi M, Oda Y, Suzuki I: Maculopapular rash in the convalescent phase of Kawasaki disease: case series and literature review. Eur J Pediatr 2013, 172:405-407.
• [3]Coustasse A, Larry J, Lee D: Can Kawasaki disease be managed? Perm J Spring 2012, 16(2):70-72.
• [4]Yokouchi Y, Oharaseki T, Harada M, Ihara F, Naoe S, Takahashi K: Histopathological study of lymph node lesions in the acute phase of Kawasaki disease. Histopathology 2013, 62:387-396.
• [5]Burns JC, Shike H, Gordon JB, Malhotra A, Shoenwetter M, Kawasaki T: Sequelae of Kawasaki disease in adolescents and young adults. J Am Coll Cardiol 1996, 28(1):253-257.
• [6]Fujiwara H, Hamashima Y: Pathology of the heart in Kawasaki disease. Pediatrics 1978, 61(1):100-107.
• [7]Choi YS, Youn HJ, Park CS, Oh YS, Chung WS, Kim JH: High echogenic thickening of proximal coronary artery predicts the far advanced coronary atherosclerosis. Echocardiography 2009, 26(2):133-139. doi:10.1111/j.1540-8175.2008.00766.x. Epub 2008 Nov 1
• [8]Gradus-Pizlo I, Feigenbaum H: Imaging of the left anterior descending coronary artery by high-frequency transthoracic and epicardial echocardiography. Am J Cardiol 2002, 90(10C):28L-31L.
• [9]Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA, Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease; Council on Cardiovascular Disease in the Young; American Heart Association: Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004, 114(6):1708-1733. Erratum in: Pediatrics 2005 Apr;115(4):1118
• [10]Council on Cardiovascular Disease in the Young: Diagnostic guidelines for Kawasaki disease. Circulation 2001, 103(2):335-336.
• [11]Gradus-Pizlo I, Sawada SG, Wright D, Segar DS, Feigenbaum H: Detection of subclinical coronary atherosclerosis using two- dimensional, high-resolution transthoracic echocardiography. J Am Coll Cardiol 2001, 37:1422-1429.
• [12]Perry R, Joseph MX, De Pasquale CG, Chew DP, Yiu D, Aylward PE, Mangoni AA: High resolution transthoracic echocardiography of the left anterior descending coronary artery: a novel non-invasive assessment of coronary vasoreactivity. J Am Soc Echocardiography 2008, 21(2):134-138.
• [13]Perry R, De Pasquale CG, Chew DP, Brown L, Aylward PE, Joseph MX: Changes in left anterior descending coronary artery wall thickness detected by high resolution transthoracic echocardiography. Am J Cardiol 2008, 101(7):937-940.
• [14]Japanese Circulation Society Joint Research Group: Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease. Pediatr Int 2005, 47:711-732.
• [15]Sasaguri Y, Kato H: Regression of aneurysm in Kawasaki disease: a pathological study. J Pediatr 1982, 100:225-231.
• [16]Galassi AR, Tomasello SD, Crea F, Costanzo L, Campisano MB, Marza’ F, Tamburino C: Transient impairment of vasomotion function after successful chronic total occlusion recanalization. J Am Coll Cardiol 2012, 59:711-718.
• [17]Kato H, Inoue O, Ichinose E, Akagi T, Sato N: Intracoronary urokinase in Kawasaki disease: treatment and prevention of myocardial infarction. Acta Paediatr Jpn 1991, 33:27-35.
• [18]Takahashi K, Oharaseki T, Naoe S: Pathological study of postcoronary arteritis in adolescents and young adults: with reference to the relationship between sequelae of Kawasaki disease and atherosclerosis. Pediatr Cardiol 2001, 22(2):138-142.
• [19]Iemura M, Ishii M, Sugimura T, Akagi T, Kato H: Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function. Heart 2000, 83(3):307-311.
• [20]Tsaousi A, Williams H, Lyon CA, Taylor V, Swain A, Johnson JL, George SJ: Wnt4/β-catenin signaling induces VSMC proliferation and is associated with intimal thickening. Circ Res 2011, 108(4):427-436.
• [21]Owens GK: Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 1995, 75:487-517.
• [22]Chien AJ, Conrad WH, Moon RT: A Wnt survival guide: from flies to human disease. J Invest Dermatol 2009, 129:1614-1627.
• [23]Uglow EB, Slater S, Sala-Newby GB, Aguilera-Garcia CM, Angelini GD, Newby AC, George SJ: Dismantling of cadherin-mediated cell-cell contacts modulates smooth muscle proliferation. Circ Res 2003, 92:1314-1321.
• [24]Slater SC, Koutsouki E, Jackson CL, Bush RC, Angelini GD, Newby AC, George SJ: R-cadherin:_-catenin complex and its association with vascular smooth muscle cell proliferation. Arterioscler Thromb Vasc Biol 2004, 24:1204-1210.
• [25]Quasnichka H, Slater S, Beeching C, Boehm M, Sala-Newby G, George S: Regulation of smooth muscle cell proliferation by _-catenin/TCF signaling involves modulation of cyclin D1 and p21 expression. Circ Res 2006, 99:1329-1337.
• [26]Wang X, Xiao Y, Mou Y, Zhao Y, Blankesteijn M, Hall JL: A role for the _-catenin/T-cell factor signaling cascade in vascular remodeling. Circ Res 2002, 90:340-347.
• [27]Wang X, Adhikari N, Li Q, Hall JL: The LDL receptor related protein LRP6 regulates proliferation and survival through the Wnt cascade in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2004, 287:H2376-H2383.
• [28]Mao C, Malek T-BO, Pueyo ME, Steg PG, Soubrier F: Differentitial expression of rat frizzled-related frzb-1 and frizzled receptor fz1 and fz2 genes in the rat aorta after balloon injury. Arterioscler Thromb Vasc Biol 2000, 20:43-51.
• [29]Ezan J, Leroux L, Barandon L, Dufourcq P, Jaspard B, Moreau C, Allieres C, Daret D, Couffinhal T, Duplaa C: FrzA/sFRP-1, a secreted antagonist of the Wnt-Frizzled pathway, controls vascular cell proliferation in vitro and in vivo. Cardiovasc Res 2004, 63:731-738.